Style
Deep ValueTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Alumis Inc.(ALMS) | 5,896,995 | $165.9M | 45.81% |
| 2 | CG Oncology, Inc.(CGON) | 1,079,050 | $76.7M | 21.17% |
| 3 | Disc Medicine, Inc.(IRON) | 374,069 | $27.4M | 7.55% |
| 4 | Hims & Hers Health, Inc.(HIMS) | 738,151 | $25.6M | 7.07% |
| 5 | Pharvaris N.V.(PHVS) | 664,142 | $23.0M | 6.34% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 97.98% | 89.98% | -8% |
| Unclassified | 2.02% | 10.02% | +8% |
Quarter-over-quarter weight changes by market cap
| Eikon Therapeutics, Inc.(EIKN) |
| 1,318,983 |
| $17.2M |
| 4.75% |
| 7 | Odyssey Therapeutics, Inc.(ODTX) | 713,105 | $13.3M | 3.68% |
| 8 | Lyell Immunopharma, Inc.(LYEL) | 476,386 | $6.7M | 1.85% |
| 9 | Nurix Therapeutics, Inc.(NRIX) | 265,000 | $6.4M | 1.77% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 87.78% | 81.6% | -6.18% |
| Unclassified | 2.02% | 10.02% | +8% |
| Micro Cap | 5.15% | 4.75% | -0.4% |
| Small Cap | 5.05% | 3.62% | -1.43% |
Quarter-over-quarter position changes